IPOS Call for Board Nominations for 2017 – 2019 Term

The International Psycho-Oncology Society (IPOS) is now accepting nominations to be on the Board of Directors. The deadline to submit is May 19, 2017 with the official start of the term commencing on August 18, 2017.

Individuals with a current “Active” membership type from across the globe are encouraged to submit nominations for the volunteer Board positions noted below. The following positions are open for nomination by individuals who hold an ACTIVE membership type:

  1. One Vice President position
  2. One Secretary position
  3. Three individual Director positions:
    • One Director from the targeted regions of India, Russia and Africa.
    • One Director from the United States.
    • One Director from Canada.

New this year is a board position for an Early Career member. This new board position, which was approved by the membership earlier this year, is to ensure our early career members have representation. The following position is open for nomination by individuals who hold an “Early Career Psycho-Oncology Professionals (ECPP)” membership type:

  1. One Early Career Director

Position Descriptions:

We recommend downloading the 2017 IPOS Nomination Information Package for a description of each position open for nomination as well as a breakdown of expectations.

To Submit a Nomination:

  1. Please download and complete the 2017 Nomination Acceptance form.
  2. Include one completed Nominator form from a fellow current IPOS member with an active membership.
  3. In a single document (Word file please) your Election Candidate Summary (to be used in the election packaged shared with voting members). This summary should include the following:
    • Name and suffix, current employment position, employer name, city, prov/state, country
    • Point form highlights of your experience with IPOS
    • Current picture
    • Current Biography – brief 100 to 200 words maximum.
    • Candidate Statement – outline of why you want to serve on the IPOS board and your election platform. 100 to 300 words maximum.
  4. Completed nominations are to be sent to IPOS by email to [email protected] by May 19, 2017.

Important Nomination and Election Timelines:

  • Release of call for nominations: March 29, 2017
  • Nomination Deadline – May 19, 2017
  • Ballots to be issued to all voting members – May 24, 2017
  • Voting Closes – June 30, 2017
  • Notification will be included in the 2017 IPOS AGM package emailed to all members by July 31, 2017.
  • Official term commences August 18, 2017.

Remember to make sure you have a current membership with IPOS for 2017 before submitting. Details are further down below on how to join/renew.


Join/Renew your IPOS membership for 2017

Have you already joined or renewed with IPOS for 2017? Just click the “Register Now” below to become a member for 2017.

Credit card payments are accepted online. If you would like to pay by cheque or prefer not able to pay online, please contact IPOS to request a hard copy dues invoice (for renewing members) or download and complete a membership application (for new members).

For a complete breakdown of the benefits of membership with IPOS, please go to http://ipos-society.org/member-benefits/.

2017 Membership Pricing:

Active membership:

Associate membership:

Early Career Psycho-Oncology Professionals (ECPP) membership:

  • $25 US for all Early Career professionals from all countries
  • ECPP membership requirement: practicing but within three years of final training (years 2014 to 2017 of last year of training. Individuals where last year of training was 2013 or before need to become Active or Associate members)

Members-in-Training membership:

  • $25 US for all Members-in-Training from all countries

Minister Dick message for Cancer Council Queensland – Professor Jeff Dunn AO – March 2017

IPOS Secretary, Professor Jeff Dunn AO retirement recognition as CEO of Cancer Council Queensland from Cameron Dick, PM, Minister of Health and Ambulance Services, Australia. Watch the video by going to https://vimeo.com/207233272/0b63778a8b

Congratulations Dr. Dunn!

IPOS Accepting Applications for the Honorary Position of Co-Editor

The International Psycho-oncology Society Newsletter was launched in 2015 as a quarterly online website publication.

Applications are invited for the Honorary Position of Co-Editor.

One vacancy is currently available in the first instance for an appointment period of two years from April 2017 to March 2019. The applicants must be able to commit to approximately 12 hours per month.

Enthusiasm, interest in the IPOS community, IT and online skills are the major requirements for applicants. Prior editing experience will be valuable but is not a requirement.

Early career psycho-oncologists are encouraged to apply.

The positions provide an opportunity for the two Co-Editors to reach out and become familiar with the IPOS community and our Federated Societies from around the world.

The Co-Editor will work, in the first instance alongside Dr Simone Cheli (Co-Editor), Dr Maggie Watson (IPOS Communications and Publications Committee) and Dr Mary-Jane Esplen (IPOS Website Committee).

Applications should include:

  1. A brief biosketch
  2. A summary of your vision for the development of the Newsletter (no more than 400 words)
  3. Confirmation that you are an IPOS member

Please send items 1 to 3 to Dr. Maggie Watson by email.

Application closing date is 31 March 2017

Position Statement: Protecting Human Rights and Travel Freedom for Cancer Patients and their Families, Researchers and Providers of Cancer Care

Authored by the IPOS Human Rights Task Force

Released: March 7, 2017

The International Psycho-Oncology Society (IPOS) is committed to the wellbeing and quality of life of cancer patients and survivors and their families worldwide. Therefore, IPOS advocates for humane physical and emotional care for refugees and immigrants worldwide without discrimination, as provided for in the Geneva Convention, especially those with cancer.

Given our organization’s focus on the well-being of cancer patients everywhere, we recognize the necessity for pediatric and adult cancer patients to travel freely to access medical, psychosocial and supportive care and for caregivers to travel freely to provide support for ill patients and other family members. When treatment is no longer effective, we recognize the right of every individual to palliative care and dying with dignity and the right of the loved ones to gather to honor and mourn their losses.

IPOS also supports international efforts to train health care providers in clear communication with patients and family members, support for shared decision-making and consideration of cancer patients’ states of distress and psychosocial needs. Freedom for researchers and care providers to acquire appropriate training, to work collaboratively in advancing care of cancer patients and to share ideas at international conferences is crucial to the rapid dissemination of research findings and progress in cancer care. Hence, IPOS strongly condemns the emergence of unjust and discriminatory policies which erect barriers that unnecessarily disrupt and disrespect the lives of many innocent people, among them, refugees from states with civil unrest, migrants needing cancer care, caregivers, and researchers and educators working to find cancer cures and to improve human health and well-being. These policies undermine the sense of community and collaboration which drives progress internationally. We encourage others to join us in sharing the responsibility of civil societies to protect those whose lives are made vulnerable by illness of any sort, by social unrest, poverty, or war.

Founded in 1984, the International Psycho-Oncology Society (IPOS) was created to foster international multidisciplinary communication about clinical, educational and research issues that relate to the subspecialty of psycho-oncology and two primary psychosocial dimensions of cancer:

  1. Response of patients, families and staff to cancer and its treatment at all stages
  2. Psychological, social and behavioral factors that influence tumor progression and survival.